Investor Alert

Oct. 28, 2020, 2:39 a.m. EDT

Sanofi, GSK sign a supply deal with COVAX facility

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Mauro Orru

Sanofi SA and GlaxoSmithKline PLC signed a supply agreement with Gavi, the administrator of COVAX Facility, a mechanism for the procurement and distribution of Covid-19 vaccines, Sanofi said Wednesday.

The French pharmaceutical company said the two drugmakers intend to supply 200 million doses of their adjuvanted recombinant protein-based Covid-19 vaccine to the COVAX Facility.

Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.